Well yes, the first patient dosed was back on the 14th of April, 2021.
The last patient to be dosed under the original protocol was supposed to be 3rd Q 2021.
On the 29th of July 2021 we got an announcement (Quarterly Report) saying that 50% of the 008 patients had been screened. There were delays due to various Covid lockdown.
Now Screening to actual recruitment can still take some time but if you take a conserved approach and say that by end July 2021 we had 50% started (This was also stated in the July Quarterly at the time), then yeah, you could even say that some of the initial few patients would definitely have one year data...maybe not too many.
It was on the 26th of October, 2021 that we had news that 30 patients were through BUT the protocols had changed. So this points to 30 having 6 months and a bit more of data by now as a min. Granted they are with the old protocol and half of them are assumedly Placebo group.
At any rate we now know that by end of Sept 2022 we have the whole bunch at 56 days...easy to keep a track of the final 6 month and 12 month approx readouts from here.
DYOR
- Mozz
PAR Price at posting:
$1.27 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)